These findings highlight the critical role of stromal-tumor interactions and suggest that targeting miR-432-5p or restoring CHAC1 function could represent promising strategies to overcome chemotherapy resistance in prostate cancer (Zhao et al., 2024). Here, CHAC1 is linked to prostate carcinoma.